SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-049499
Filing Date
2024-02-28
Accepted
2024-02-28 09:26:55
Documents
17
Period of Report
2024-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d766950d8k.htm   iXBRL 8-K 33293
2 EX-1.1 d766950dex11.htm EX-1.1 195601
3 EX-5.1 d766950dex51.htm EX-5.1 15853
7 GRAPHIC g766950g0226091402204.jpg GRAPHIC 2194
  Complete submission text file 0001193125-24-049499.txt   432664

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20240228.xsd EX-101.SCH 2862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20240228_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20240228_pre.xml EX-101.PRE 11269
19 EXTRACTED XBRL INSTANCE DOCUMENT d766950d8k_htm.xml XML 3685
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 24690710
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)